Burzynski Research Institute, Inc.
|
-0.01 USD
|
-7547.059%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
65.639%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
107.536%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-5720.896%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-2329.907%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
113.109%
|
Qrons Inc.
|
-0.06 USD
|
-1237.907%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-51900.0%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-1256.522%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-7700.0%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
85.475%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
98.464%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-1414.563%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
71.739%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-792.449%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-3191.139%
|
Mesoblast Limited
|
-0.09 USD
|
-775.421%
|
Marizyme, Inc.
|
-1.44 USD
|
45.833%
|
Genus plc
|
0.12 USD
|
750.0%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
66.524%
|
Pharming Group N.V.
|
-0.02 USD
|
-4744.72%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-111328.571%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
-85.714%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-708.29%
|
ContraFect Corporation
|
-124.97 USD
|
99.376%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-1757.143%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-6400.0%
|
IMV Inc.
|
-4.37 USD
|
82.151%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-2103.39%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-779900.0%
|
ONE Bio Corp.
|
1.43 USD
|
154.545%
|
Accustem Sciences Inc.
|
-0.34 USD
|
-129.412%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
-34.483%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-550.0%
|
Q BioMed Inc.
|
-0.08 USD
|
-898.72%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-1009.531%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
-136.364%
|
Biomind Labs Inc.
|
-0.02 USD
|
-4714.815%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.9%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-10440.541%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-3819.598%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-32400.0%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-97400.0%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
-200.0%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-8763.636%
|
GB Sciences, Inc.
|
-0.00 USD
|
-18924.39%
|
Alpha Cognition Inc.
|
-0.15 USD
|
-420.0%
|
HST Global, Inc.
|
-0.03 USD
|
-2695.699%
|
CSL Limited
|
2.73 USD
|
128.571%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-1456.886%
|
Halberd Corporation
|
-0.00 USD
|
-779900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-111328.571%
|
Agentix Corp.
|
-0.04 USD
|
-2128.571%
|
Resverlogix Corp.
|
-0.01 USD
|
-5392.958%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-934.483%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
84.884%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
60100.0%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
3207.57%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-2084.874%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-3800.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-1347.124%
|
Zenith Capital Corp.
|
-0.07 USD
|
-1015.88%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-1618.062%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-12280.952%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
79.31%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-155900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-754.326%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
83.404%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
97.857%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
-25.806%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-6454.622%
|
LadRx Corporation
|
0.68 USD
|
214.706%
|
Cell Source, Inc.
|
-0.17 USD
|
-358.824%
|
Regen BioPharma, Inc.
|
0.29 USD
|
368.966%
|
Regen BioPharma, Inc.
|
0.26 USD
|
400.0%
|
NovAccess Global Inc.
|
-0.23 USD
|
-239.13%
|
Affymax, Inc.
|
-0.39 USD
|
-100.0%
|
Itoco Inc.
|
-0.01 USD
|
-10163.158%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-7700.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-31100.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-13828.571%
|
CytoDyn Inc.
|
-0.05 USD
|
-1374.48%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-155900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-3413.514%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.492%
|
SYBLEU INC
|
-0.02 USD
|
-4357.143%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-5392.958%
|
International Stem Cell Corporation
|
-0.02 USD
|
-4656.098%
|
Bioxytran, Inc.
|
-0.03 USD
|
-2345.141%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-779900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
90.238%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
33.898%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-2194.118%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-12280.952%
|
Neutra Corp.
|
-0.00 USD
|
-779900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.172%
|
PureTech Health plc
|
-2.38 USD
|
67.227%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
6.024%
|
IXICO plc
|
-0.02 USD
|
-3096.721%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-1273.239%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
42.222%
|
CSL Limited
|
5.47 USD
|
114.26%
|
Cellectis S.A.
|
-1.77 USD
|
55.932%
|